A 40% reduced risk for death from renal cancer, as reported by KEYNOTE-564, tops Dr Brian Rini's list of takeaways from ASCO GU 2024. Also discussed are updates on doublet therapy in advanced disease.
Adjuvant IO: Survival Advantage 'Big News' in Renal Cancer
1 year ago
28
- Homepage
- category-label-
- Adjuvant IO: Survival Advantage 'Big News' in Renal Cancer
Related
Trending
Popular
Reduce your risk of cancer: get involved and have fun
1 year ago
227
Copyright © 2019 - 2025 | Whatiscancer.net | All Rights Reserved.






English (US) ·